New Drug Application to be submitted mid-year with approval (hopefully) by December 2022/January 2023. That is 11-12months away.
Rest of World commercial partners could be announced any day.
$3 share price value for Trofinetide alone is crazy. Surely if drug is approved the share price goes to $10/minimum. Risk vs reward for an 11month wait......
Looking forward to this quarterly (released tomorrow or Monday) to give an update on the IND applications for planned phase 2 trials for NNZ-2591.
Share Price, page-765
-
- There are more pages in this discussion • 11,477 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.18 |
Change
-0.430(3.16%) |
Mkt cap ! $1.684B | |||
| Open | High | Low | Value | Volume |
| $13.64 | $13.67 | $13.18 | $8.868M | 666.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 5233 | $13.18 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.24 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 09/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |